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Abstract 
The purpose of this quality improvement project was twofold: (a) conduct semi-
structured interviews to explore the beliefs and current practices of Nurse Practitioners (NPs) 
that prescribe antibiotic therapy in the outpatient setting, regarding probiotic products, and (b) 
compare these beliefs and practices to the best current evidence.  A synthesis of the literature 
was conducted to describe and critically analyze current best practices of probiotic use in the 
clinical setting.  The results from the semi-structured interviews may augment practice 
recommendations in clinic settings and effectiveness of probiotics as adjunctive treatment.  An 
executive summary for dissemination to key stakeholders was produced.   
The project design included qualitative semi-structured interviews of nine NPs identified 
using a snowball recruitment method.  Responses were recorded on an interview form and 
common themes to each question were analyzed.  Responses were also compared to current 
evidence-based literature from sixteen peer-reviewed articles that examined the effectiveness of 
probiotics in the prevention or treatment of certain antibiotic associated side effects. 
Although the practitioners’ beliefs of symptoms to address with probiotics were generally 
consistent with current best evidence, gaps in knowledge were identified.  The recommendation 
of probiotic strains and the number of cultures contained in the supplement were discussed in 
some interviews but was not always in agreement with the literature.  Similarly, suggestions 
regarding the frequency and timing of dosing between the probiotic and the antibiotic 
recommended by the practitioners were often inconsistent with the research findings.   
The main recommendation for the use of probiotics is to suggest probiotics when 
antibiotics are prescribed to prevent or treat antibiotic-associated diarrhea.  For this use, yogurts 
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containing added live cultures or enteric-coated capsules are most effective.  Products should 
contain 1-10 billion units of probiotic bacteria, be taken three to four times daily, and be 
continued for two weeks after the antibiotic is complete.  Doses of probiotics and antibiotics 
should be separated by two to four hours to prevent destruction of the probiotic in the GI tract.  
Probiotics should be avoided in patients with high fevers or immunodeficiency.  Current 
evidence suggests that probiotics are not effective to prevent or treat vulvovaginal candidiasis. 
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Chapter One: Overview of the Project 
Introduction to the Problem 
 Antibiotics are powerful medications responsible for saving millions of lives and play a 
pivotal role in medical advancement (Ventola, 2015).  Patients frequently seek antibiotics for 
mild illnesses and viruses such as the common cold; healthcare practitioners often prescribe them 
to appease patient requests (Ventola, 2015).  Unfortunately, this practice is a misuse of 
antibiotics resulting in the over prescription of antibiotics which has blunted their impact in the 
treatment of bacterial infections (Ventola, 2015).  According to the Centers for Disease Control 
and Prevention (CDC), in 2104, 266 million courses of antibiotics were dispensed in the United 
States (CDC, 2016).  That equates to one antibiotic prescription each for 83 percent of the 
population annually. 
A problem associated with antibiotic treatment is that the antibiotics not only kill bacteria 
associated with infection, but also inhibits the body’s natural bacterial flora creating an 
environment favoring potential pathogens such as candida (Sobel, 2015).  When the balance of 
good bacteria is disrupted, a condition called dysbiosis (e.g., microbial imbalance) occurs, 
potentiating a wide range of possible side effects including diarrhea, stomach upset, overgrowth 
of resistant bacteria such as Clostridium difficile  (C. diff), and fungal over-growth (Rodgers, 
Kirley, & Mounsey, 2013).  Fungal over-growth leads to oral thrush, skin infections, and 
vulvovaginal candidiasis (VVC) commonly known as vaginal yeast infection (Gillies, 
Ranakusuma, Hoffmann, Thorning, McGuire, Glasziou, & Del Mar, 2015).   
Uncomfortable symptoms associated with antibiotic-associated side effects such as VVC 
are a main reason for patient treatment non-compliance and discontinuance of antibiotic therapy 
(Rodgers, et.al.,).  The World Health Organization (2015) recognizes incomplete antibiotic 
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treatment as a key contributor in the creation of antimicrobial-resistant organisms and as a 
serious hazard to global public health threatening effective prevention and treatment of infections 
caused by bacteria, viruses, parasites, and fungi.  Increasing medication compliance as well as 
reducing the need for antifungal medications can help to prevent antimicrobial resistance.   
Women of child-bearing age are particularly susceptible to antibiotic-associated VVC.  
According to Sobel, one quarter to one third of women experience VVC after taking a broad-
spectrum antibiotic (2015).  Women prone to VVC often request prescriptions for Diflucan, an 
antifungal medication, at the time an antibiotic is prescribed.  Women often self-manage the 
fungal infection with probiotics (Pirotta & Garland, 2005) or with prescribed Diflucan.  A recent 
study revealed that as few as 11% of women correctly self-diagnose VVC infections following 
antibiotic use, although the number of cases of correctly self-diagnosed VVC could be as high as 
35% in women who had been professionally diagnosed previously with VVC (Sobel, 2015).  The 
over prescription of antifungal treatment such as Diflucan is a healthcare provider issue 
contributing to microbial resistance (WHO, 2015), and is associated with drug resistant strains of 
Candida (Hu, Merenstein, Wang, Hamilton, Blackmon, Chen, & Li, 2013).  VVC can be caused 
by antibiotic use and is a common reason for early discountenance of antibiotic treatment (Sobel, 
2015).   
Medication compliance is essential for effective management of disease.  The side effects 
of gastrointestinal upset and VVC are frequent causes of antibiotic noncompliance.  Evidence-
based identification of correct indications, doses, strains of probiotic organisms, and patient 
education of probiotics may help to reduce side effects and improve compliance (Pirotta & 
Garland, 2005).  Understanding these factors enables practitioners to safely recommend 
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probiotics that have strong evidence benefitting patients and the preservation of future antibiotic 
effectiveness. 
Significance to Nursing  
The issues of minimizing side effects and maximizing antibiotic compliance are relevant 
to nursing and to effective healthcare delivery overall, as Nurse Practitioners (NPs) have become 
major providers of care and advocates for patients in the primary care environment.  The CDC 
(2016) reports that 80-90% of antibiotic prescriptions are written in the outpatient setting.  
According to the American Association of Nurse Practitioners (2016), 83% of NPs work in 
primary care; those working full time write an average of 23 prescriptions each day including 
antibiotic prescriptions.  As prescribers of antibiotics, NPs must prescribe based on the best and 
current evidence as well as guidelines for care to ensure improved medication compliance, 
proper patient education, and better patient outcomes. 
In the primary healthcare environment, head, eye, ear, nose & throat (HEENT) infections 
such as streptococcal pharyngitis (Chow & Doron, 2013), acute otitis media, and sinusitis are 
common reasons that patients seek care that result in antibiotic treatment (American Academy of 
Otolaryngology, 2016).  First-line treatments for these infections are penicillin-based antibiotics 
such as Amoxicillin, Augmentin, and Phenoxymethylpenicillin (PenVK) that require a seven to 
ten day course of care (American Academy of Otolaryngology, 2016).  These medications are 
known to cause VVC for as many as 33% of women taking antibiotics for non-urogenital 
purposes (Sobel, 2015) contributing to antibiotic non-compliance and use of antifungal 
treatments such as Diflucan. 
It is estimated that more that 30% of people who take antibiotics will experience some 
degree of adverse effects associated with the disruption of flora (McFarland, 2015).  Recently, it 
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has become more common for healthcare providers prescribing antibiotics to recommend taking 
a probiotic when ordering an antibiotic for a patient (Rodgers, et al., 2013).  According to 
McFarland (2015) patients depend on healthcare providers for information on probiotics, but 
instead many patients receive information on probiotics from web-based sources found on the 
Internet.  Credibility of effectiveness claims regarding probiotics contrast greatly from Pirotta & 
Garland (2005) claiming decades of acceptance of probiotics as a “folk remedy” for VVC 
prevention to 98% of gastroenterologists expressing belief in probiotics for flora imbalance 
treatment including some yeast infections and gastrointestinal symptoms (Rodgers, et al., 2013).  
To properly advise patients, NPs need to be guided by evidence-based practice in order to make 
recommendations that will benefit patients and lead to better health outcomes. 
 Antibiotic resistance is a concern to nursing, healthcare, and public health.  In 2016, 
“superbugs” resistant to all known antibiotics have surfaced, resulting in increased patient 
mortality (Chen, Todd, Kiehlbauch, Walters, & Kallen, 2017).  To address antibiotic use, the 
White House National Action Plan for Combatting Antibiotic-Resistant Bacteria (2015) was 
formed to reduce inappropriate outpatient antibiotic use by 50 percent by the year 2020, 
including reducing antibiotics prescribed for otitis media by 50%.  As antibiotic non-compliance 
has been identified as a primary contributor in microbial resistance, nurse leaders such as Doctor 
of Nursing Practice prepared nurses must work to improve evidenced-based practice by creating 
and implementing guidelines and protocols based on current best evidence.  This standardization 
of practice will reduce non-compliance and prevent microbial resistance.   
Purpose 
The purpose of the quality improvement project was twofold: (a) to conduct semi-
structured interviews to explore the beliefs and current practices of nurse practitioners that 
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prescribe antibiotic therapy regarding probiotic products, and (b) compare these beliefs and 
practices to the best current evidence.  A synthesis of the literature was conducted to describe 
and analyze best practices of uses for probiotics in the clinical setting.  The results from the 
semi-structured interviews may identify a need for practice change or augment practice 
recommendations for the use of probiotics as adjunctive treatment.  An executive summary for 
dissemination to key stakeholders was produced (see Appendix F).   
Clinical Practice Problem Statement  
Among nurse practitioners prescribing antibiotics for adult age women with HEENT 
infections, how do their beliefs and practices regarding probiotic use compare with evidence-
based practice recommendations to prevent vulvovaginal candidiasis? 
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Chapter Two: Review of Literature 
Many clinical indications for probiotics have been studied in the literature including 
bacterial vaginitis (McFarland et.al, 2015; Abad & Safdar, 2009), VVC (Abad & Safdar, Hu, 
et.al, 2013, Gillies, et.al, 2015), oral thrush (McFarland, et.al, 2015, Hu, et.al 2013), antibiotic-
associated diarrhea (Avadhani & Steefel, 2015; McFarland et.al, 2015; World Gastroenterology, 
2011), and C.Diff infections (McFarland et.al, 2015; World Gastroenterology, 2011).  Although 
initial searches focused mainly on probiotic use associated with VVC, stronger evidence was 
identified for clinical uses of probiotics associated with gastrointestinal disturbances during 
antibiotic therapy (Avadhani & Steefel, 2015; McFarland et.al, 2015; World Gastroenterology, 
2011).  Additional studies acknowledged the usefulness of probiotics in treating oral thrush, skin 
infections, and overall immune health (McFarland, et.al, 2015).  No studies were located that 
addressed nurse practitioners recommending probiotic use for any purpose.   
Literature Review 
The project design is conceptually guided by a quality improvement framework that 
began with a systematic literature search on the topic using inclusion and exclusion criteria, 
collection and analysis of the level-of-evidence, and recommendations in relation to the existing 
published research and practice guidelines.  The resulting data were compiled into a literature 
synthesis table (see Appendix A) and evaluated for level and quality of evidence.  Specifically, 
the project followed the Six Sigma methodology.  Six Sigma is a problem-solving method using 
the five-step DMIAC Process for quality improvement (Moran, 2012).  The steps of the DMAIC 
process are: Define measure, analyze, improve, and control.  The purpose of quality 
improvement drives this design because this project focuses on the improvement of a practice-
based concern. 
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The evidence used to develop this quality improvement project resulted from a systematic 
review of the literature focused on peer-reviewed, published research on probiotic use with 
antibiotics.  Inclusion criteria included studies: (a) focused on treatment of antibiotic-induced 
yeast infections, (b) comparing probiotic use in combination with an antibiotic to antibiotic use 
alone, (c) examining yeast infections and probiotics, (d) including women between the ages of 21 
and 45 years old, and (e) studies that address administration frequency, timing, and dosing of 
probiotics for adjunct clinical use with antibiotic therapies.  Exclusion criteria included oral yeast 
infections such as thrush, skin infections, men, children, and women younger than 21 or older 
than 45 years of age.   
First, online database literature searches were performed through the Health Sciences 
Library at Ohio State University using the Cumulative Index to Nursing and Allied Health 
Literature (CINAHL) and Medical Literature Analysis and Retrieval System Online (MEDLINE) 
databases.  The search/MEsH terms employed included: antibiotic, probiotic, lactobacillus, yeast, 
candidiasis, fungal, vaginal, vaginitis, vulvovaginal, prevention, prophylactic, treatment, and 
female.  Initial results identified 78 articles, of which 34 were selected for review (9 duplicates 
were removed, and 25 articles met exclusionary criteria).  Sixteen papers were determined to be 
relative to this project and are included in this review and in the synthesis table (see Appendix 
A).  Of the 16 included papers: three were systematic reviews, four were randomized control 
trials, four were pilot or mixed method studies, and five were expert opinions.   
Next, the papers identified were analyzed for strengths and limitations using the Rating 
System for the Hierarchy of Evidence (Melynk, 2011) in which study designs are rated for 
reliability and minimizing bias.  Using this scale, levels of evidence were applied using the 
Center for Transdisciplinary Evidence Based Practice Rapid Critical Appraisal Tool (Melnyk, 
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2011).  The appraisal process was used to identify best practices for clinical decision-making, 
therefore the data must be of the highest statistical worth on which to base clinical change 
(Moran, Burson, & Conrad, 2014).  Level I evidence, that with the highest worth included 
systematic reviews by Abad & Safdar (2009) and Hanson, VandeVusse, Jerme, Abad, & Safdar, 
(2016).  Level II evidence includes randomized controlled studies (RCTs) such as Bohbot & 
Cardot (2012), Hu, et al.  (2013), Pendharkar, Brandsborg, Hammarstrom, Marcotte, & Larsson, 
(2015), Chew & Than (2016), Pirotta, Gunn, Chondros, Grover, O’Malley, Hurley, & Garland, 
(2004), Tomusiak, Strus, Heczko, Adamski, Stefański, Mikołajczyk-Cichońska, & Suda-
Szczurek, (2015).  Level III evidence includes controlled studies such as Vicariotto, Del Piano, 
Mogna, & Mogna, (2012).  Level VII evidence includes expert opinion articles such as 
McFarland (2015), Neafsey (2005), Pirotta & Garland (2005), Reid & Bruce (2003), Grazul, 
Kanda, & Gondek (2015). 
While the evidence from the peer reviewed research overall was not found to be 
statistically significant in support of probiotics for VVC, preventatively or curatively, several 
studies did note encouraging findings that warranted further research.  For example, Vicariotto, 
et al., (2012) stated, “probiotics are emerging as a new strategy to counteract VVC” (pg. 73), 
noting that probiotics helped establish a natural barrier to some yeasts by decreasing intervaginal 
pH.  They also found that by using slow release vaginal probiotic tablets a decrease in recurrent 
VVC, not associated with antibiotic use was noteworthy.  Similarly, Hanson et al., (2016) state 
“it is plausible that more investigation would have had significant findings if antibiotic and 
probiotic interventions were more carefully timed and clearly reported” (pg. 353).  Pirotta, et al., 
(2004) note that most trials to date have been methodically poor, lacking adequate concealment, 
randomization, or control.  Although at this time evidence is weak to support clinical use of 
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probiotics for VVC, future studies may identify the specific strains, doses, and routes of 
administration to be clinically significant. 
Bobhot & Cardot (2012) suggest that great variability in clinical results is due to the 
number of variables being studied.  Too many variables with small samples can lead to non-
significant findings even when one exists.  Bobhot & Cardot recommend that the variation in 
probiotic preparations, routes of administration, and duration of treatments require rigorous 
clinical trials to further investigate dosing and vaginal uptake (2012).  Pendharkar, Brandsborg, 
Hammarstrom, Marcotte, & Larsson (2015) further suggest that for child-bearing age women 
menstrual cycle stage as a factor important to vaginal uptake of probiotics for VVC prevention 
and treatment is not well understood but should be considered for studies.  Further, Tomusiak et 
al., (2015) identified three Lactobacillus strains most effective in vaginal uptake and the effect on 
vaginal pH, a measure thought to be key in the development of VVC.  Their study combined the 
three strains into a single intravaginal product found to be effective in a placebo-controlled trial.  
These studies indicate that more robust research is being done to identify strains and doses of 
Lactobacillus effective in restoring vaginal microbiota to prevent or treat VVC.  This promising 
research may lead to better evidence to guide practice.   
Some researchers discussed concern for the ability of probiotics to survive the GI tract in 
order to exert their effectiveness.  McFarland (2015) noted the importance of using strains 
resistant to gastric and bile acidity, while Hanson, et al., (2016) advocate separating antibiotic 
and probiotic doses by at least two hours declaring that the antibiotic could destroy the probiotic 
in the GI tract.  Enteric-coated probiotic capsules protect the cultures from stomach acid, 
allowing absorption in the small intestine (Bobhot & Cardot, 2012).   
EVIDENCE BASED PRIOBIOTIC RECOMMENDATIONS 
 
13 
Several authors specified lactobacillus, which Neafsey & Donat (2005) described as 
having a greater ability to transfer and colonize vaginally.  Bobhot & Cardot (2012) state that 
Lactobacillus is fundamental for eco balance of the vagina.  Reid & Bruce distinguish 
Lactobacillus rhamnosus and Lactobacillus fermentium as having some activity in the inhibition 
of Candida yeasts (2003).  Many strains and combinations were studied; lactobacillus and 
acidophilus (Vicariotto, et al., 2012), Lactobacillus casei rhamnosus (Bobhot & Cardot, 2012), 
and Lactobacillus rhamnosis,  Lactobacillus gasseri (Pendharker, et al., 2015).  A study by 
Tomusiak, et al, (2015) successfully used a probiotic product that contained three strains of 
Lactobacillus in a study compared to placebo. 
Yogurt is a common probiotic, but it is important to know that not every yogurt is a 
probiotic (McFarland, et al., 2015).  Mixed results were found using yogurt as a probiotic, with 
positive results reported using yogurt with added live or active probiotic cultures (Hu, H., et al., 
2013).  Pirotta & Garland (2005) felt that yogurt was too unstable to be seriously considered due 
to shelf life and low standards of quality control; further noting that yogurt is held to food 
standards, not pharmaceutical standards and depended instead on isolated probiotics for both oral 
and vaginal administration. 
With limited statistical findings, researchers agree that probiotics may have some promise 
in the prevention of antibiotic associated VVC; all studies concluded that more research is 
needed.  Probiotics are considered to be complementary/alternative medicines (CAM) and 
therefore do not have the monetary research funding priority compared to pharmaceutical studies 
(Pirotta, et al., 2004).  Despite probiotics being a $48 billion dollar a year industry, only six 
percent of probiotic research focuses on vaginitis, and only a fraction of that specifically studies 
VVC (McFarland, 2015).  Up to 30% of women experience antibiotic-induced VVC when using 
EVIDENCE BASED PRIOBIOTIC RECOMMENDATIONS 
 
14 
broad-spectrum antibiotics, a problem that affects medication compliance.  If researchers have 
found encouraging results, research should continue to advance clinical practice and improve 
patient outcomes.   
It is important to note that though probiotics as prophylaxis or treatment for VVC is still 
being investigated, their use as adjunct therapy to antibiotics is well documented for antibiotic-
induced gastrointestinal symptoms.  Probiotic use as a preventative measure for antibiotic 
associated diarrhea and C. diff is well documented in the World Gastroenterology Organization 
Global Guidelines (2011), and studies conducted by Pattani, Palda, Hwang, & Shah (2013).  No 
studies have determined probiotic use or supplementation with probiotics to be harmful in any 
way. 
Gaps in Evidence 
An exhaustive literature review reveals that the evidence to support the pairing of 
probiotics with antibiotics to prevent VVC is weak though research continues attempting to 
identify strains and preparations of probiotics effective for VVC.  Further research is needed to 
better understand the pathogenesis and treatment of post-antibiotic VVC.  These gaps highlight 
opportunities for future research to improve clinical practice.   
Quality of probiotics is cited as a concern (Abad & Safdar, 2009).  Probiotics are 
considered to be dietary supplements and are not regulated by the United States Food and Drug 
Administration (FDA), so manufacturing techniques, claims of effectiveness, or actual contents 
of the supplement are not assured (National Institute of Health, 2015).  Studies by Vicariotto et 
al., (2012), Tomusiak, et al., (2015), Abad & Safdar, (2009) identify timing, dosing, and optimal 
administration routes as areas needing further clarification in research.  Hanson, et al., (2016) say 
more measurable purposes and outcomes need to be explored.  Six percent of probiotic research 
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focuses on vaginitis, and a fraction of that specifically studies VVC (McFarland, 2015).  
Allocating better funding will enable researchers to perform more and better research to identify 
strains, doses and routes with better efficacy.   
 The literature search yielded no findings related to nurse practitioner or healthcare 
provider practices regarding probiotic recommendation and patient education.  Addressing these 
gaps can help to ensure that nurse practitioners are practicing using current evidence, and 
teaching patients safely and effectively how to care for their own health. 
Theoretical Framework 
The theoretical framework utilized for the development of this project is Promoting 
Action on Research Implementation in Health Services (PARIHS) as defined by Kitson, Harvey, 
& McCormack (1998).  This framework is useful as a guide to implement evidence-based 
practice into the clinical practice setting.  The three key factors of PARIHS include: Evidence, 
Context, and Facilitation (Kitson, Harvey, & McCormack, 1998). 
Evidence.  Evidence refers to not only the literature and research that is to be translated 
into practice, but includes practitioner expertise and experience, the intended population to be 
affected, and the context or environment (Kitson, et al., 1998).  These factors fit well with this 
project in comparing the best evidence to nurse practitioner perceptions and beliefs.  These 
findings can be translated into clinical practice for applicable patients.   
Context.  Context encompasses the culture, environment, and implementation strategies 
of change to be applied (Kitson, et al., 1998).  In the case of this quality improvement project, 
this aspect takes factors such as patients at risk and individual factors such as the antibiotic to be 
prescribed into consideration for the treatment plan.  The interview questions were designed to 
provide insight to the thoughts, experiences, patient teaching or education, and recommendations 
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of the nurse practitioners when prescribing antibiotics.  The results were compared with the 
current best evidence defined by the comprehensive review of the literature to identify best 
practice.   
Facilitation.  Facilitation is a process to include the practitioner’s existing knowledge 
and skill in applying the new information (Kitson, et al., 1998).  It may also be interpreted as 
enabling or empowering the practitioner in a mentoring or supportive manner.  It is a knowledge 
translation strategy that may be utilized as dissemination of evidence in this project.  An 
executive summary was created detailing findings and identifying best practices revealed in the 
project.  This summary will be made available for dissemination to nurse practitioner journals 
where nurse practitioners can update their own knowledge and practices, improving care for their 
patients. 
  
EVIDENCE BASED PRIOBIOTIC RECOMMENDATIONS 
 
17 
Chapter Three: Methodology 
Project Design and Methodology 
Evidence-based practice is the action of making clinical decisions based on the best 
current available evidence to ensure that changes to nursing practice and patient care are 
grounded in the highest quality research at the given time.  In this quality improvement project, 
this means using the best current evidence to drive probiotic use in the clinical setting.  The best 
available evidence refers to rating research on the Hierarchy of Evidence scale, recognizing that 
the highest levels of research are valid, reliable, and applicable while minimizing bias (Melnyk 
& Fineout-Overholt, 2015).  This data must be combined with practitioner expertise and clinical 
experience as well as the needs of the patient or population while fitting with the mission of the 
organization to identify and provide the highest quality of safety and care for patients. 
The Iowa Model  
The Iowa model is an evidence-based practice framework that can be applied to a clinical 
innovation ensuring a process of implementation that addresses the intricacies of change 
(Melnyk & Fineout-Overholt, 2015).  The Iowa model was used in the implementation of this 
project using the following steps: 
Assess the need for change.  The nurse practitioners interviewed are prescribing 
professionals who see patients for “sick” visits, many of these episodic visits result in a 
prescription for antibiotics.  During the nurse practitioner and patient discussion, education on 
expectations of treatment, including side effects often takes place.  The topic of probiotics may 
be discussed at that time.  This quality improvement project utilized a semi-structured tool to 
interview nurse practitioners, revealing their beliefs and practices regarding probiotic 
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recommendations (See Appendix D).  The interview tool incorporated views of key stakeholders, 
current practice(s), and relevance of health problems to outcomes.   
Locate the best evidence.  The evidence detailed in the literature review was used to 
identify the scientific basis for clinical probiotic use.  Further information to guide the practice 
was obtained in the semi-structured interviews to assess current probiotic practices and beliefs in 
the patient care setting. 
Critically analyze the evidence.  The evidence identified in the literature review 
concluded that evidence does not support the practice of using probiotics in the prevention or 
treatment of antibiotic-induced VVC, however stronger evidence does exist to use probiotics for 
many gastrointestinal side effects including gastritis and antibiotic-induced diarrhea.  The 
evidence shows when probiotics are indicated and when they should be taken for maximum 
effect.  For example, probiotics are indicated for use when taking a broad-spectrum antibiotic 
likely to cause gastrointestinal symptoms, and should be taken three to four times a day during 
the antibiotic course, and for two weeks after antibiotic completion (Avadhani & Steefel, 2015; 
McFarland et.al, 2015).   
Design a practice change.  The best evidence indicates that a current practice should 
discontinue any recommendation of probiotic use for VVC, but include probiotics to prevent 
gastrointestinal symptoms when broad-spectrum antibiotics are prescribed, in accordance with 
the recommendations as detailed in the practice change section of this paper.  Using the best 
current peer-reviewed literature and the results from nurse practitioner interviews, an Executive 
Summary for dissemination to key stakeholders was produced.  The Executive Summary 
highlighted key points: when probiotics are and are not effective in clinical use and the best ways 
to incorporate their use into the treatment plan.   
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Implement and evaluate the change in practice.  The Executive Summary was made 
available to stakeholders to disseminate results to guide clinical conversations with patients in 
the expectation, prevention and treatment of antibiotic-associated VVC and other clinical uses 
for probiotics. 
 Integrate and maintain the change.  The results of the project will be submitted for 
publication to a peer-reviewed nurse practitioner periodical.  Results will be further disseminated 
through professional conference presentations.   
Project Design 
This quality improvement project used a qualitative approach, guided by a critical 
analysis of the literature.  Six, semi-structured, open-ended interview questions were crafted to 
encourage the nurse practitioner participants to openly discuss their perceptions, beliefs, 
probiotic knowledge, and probiotic patient care practices in regard to clinical use.   
The project was a quality improvement endeavor to compare practitioner beliefs and 
perspectives combined with a critical appraisal of the current evidence to determine if practices 
regarding probiotics are grounded in the best scientific evidence.  No personal or identifiable 
health information was gathered for this project, and no patient data was utilized.  Quality 
improvement projects are not subject to Institutional Review Board (IRB) approval, thus based 
on these factors; this project was determined to be exempt from IRB approval by the Ohio State 
University (see Appendix B).  The quality improvement versus research assessment interactive 
tool was used and the verification IRB form will serve as documentation of meeting criteria for 
exemption from IRB review. 
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Sample 
 The sample included nine nurse practitioners currently practicing in the state of Ohio 
with prescriptive authority to prescribe antibiotics.  Participants were employed in a prescribing 
patient care role in an ambulatory or primary care clinic that agreed to participate in the project.   
Participants were identified using the snowball method of recruitment.  With snowball 
recruitment, each participant was asked to recommend 2-3 other nurse practitioners for possible 
inclusion.  By using snowball methods, the sample would be more diverse and representative of 
the nurse practitioner population in the geographical region.  In this snowball or referral-based 
recruitment method, initial participants were offered information sheets to voluntarily share with 
colleagues who may be appropriate for the project (Boise State University, 2016).  Potential 
participants willing to be interviewed made the initial contact with the interviewer, at which time 
an in-person; private interview was arranged at a time and location at the convenience of the 
participant.  The initial contact with one NP known to the interviewer agreed to be interviewed 
and to refer peers not known to the interviewer.  The process was slow and several potential 
subjects did not contact the interviewer.  A second contact known to the interviewer was reached 
and also agreed to be interviewed and help recruit subjects.  The overall response rate was 47%; 
nineteen invitations were extended with nine subjects completing the interview.  The response 
was adequate to reach saturation wherein common themes were emerging without generating 
new findings. 
Data Collection Process 
 The methods of this project entailed several steps.  First, the DNP student interviewer 
prepared a disclosure and consent document (see Appendix C) explaining the purpose, 
procedure, and objectives of the project.  After reading the document, nine participants elected to 
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continue and participated in an interview lasting approximately ten minutes.  Second, the 
interviewer took handwritten notes on the interview form (see Appendix D), and third, the 
interview was recorded without including identifying information about the participant.  The 
recording was destroyed after it was transcribed and notes were confirmed to be accurate.    
The interview consisted of six questions, plus follow up questions as appropriate.  
Optional demographic information was collected.  Although the questions were structured to 
avoid risks, participants were free to decline any question, and to withdraw from the interview 
altogether at any time, however no participants chose to withdraw.  Following the interview, the 
fourth step was to offer participants copies of an “Invitation to Participate” (see Appendix E) that 
they could voluntarily share with peers who may be willing to participate in the project.  It was 
expected that 6-12 interviews would be necessary to reach saturation.  Saturation is defined as 
the point at which the same responses or themes are emerging without new information being 
obtained.  For this project, saturation of findings was obtained after nine interviews were 
completed.   
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Chapter Four: Findings 
Sample Characteristics 
Nine nurse practitioner (NP) participants completed interviews over a one-month period.  
The nurse practitioners ranged in experience, from two years of practice, to 22 years in practice 
with 33% (n = 3) having more than 15 years of experience, and 44% (n = 4) having less than five 
years of experience.  Seven of the nine nurse practitioners were certified as Family Nurse 
Practitioners (FNP), one was certified as an Adult Nurse Practitioner (ANP), and one was a 
certified Pediatric Nurse Practitioner (PNP).  The sample consisted of mostly females, 88% (n = 
8) with only one male participant.  All nurse practitioners prescribed antibiotics, with practice 
settings to include primary care, retail heath, urgent care, and pediatrics.  Two of the NPs were 
working in specialty settings at this time.  All participants stated that they had no instruction 
regarding probiotics in their NP education and shared that their information regarding probiotics 
came from advertising, 33% (n = 3) and from professional journal articles, 77% (n = 7) while 
33% (n = 3) also reportedly gained information from colleagues. 
Survey Questions and Responses 
Question 1: What are your thoughts and experiences regarding the clinical 
recommendation of probiotics for patients? 
All NPs interviewed expressed their perceived effectiveness of probiotics in managing GI 
symptoms such as diarrhea, while 55% (n = 5) discussed the importance of maintaining balance 
of natural flora.  Specific patient scenarios were identified by 55% (n = 5) of the interviewees in 
their decision to recommend probiotics, noting that probiotics were useful in cases following 
colonoscopy, after viral illness, during periods of GI upset or heartburn, and with antibiotic use.  
Several interviewees noted that populations most likely to be receptive to probiotics were women 
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ranging in age from about age 40 to 60 years old, and those with a higher health IQ.  Three NPs 
noted a lower level of receptiveness in patients of a lower socioeconomic status, which they 
speculated as being due to some combination of health literacy and being able to afford the 
additional products which might not be covered by insurance. 
Question 2: Do you prescribe antibiotics? If so, what is your experience with the efficacy 
of probiotics to prevent or treat antibiotic-associated side effects? 
All nine nurse practitioners interviewed had experience prescribing antibiotics.  Specific 
antibiotics likely to cause side effects were identified by more than half of the interviewees 
(55%).  Three nurse practitioners said Augmentin caused side effects; Macrolide antibiotics such 
as Azithromycin were noted by two NPs as causing side effects; and broad-spectrum antibiotics 
were stated by two NPs without naming a specific drug.  One NP noted conditions needing 
higher doses of antibiotics as likely to increase side effect symptoms, and another NP mentioned 
cases where a second round of antibiotics was necessary.  In five interviews (55%), nurse 
practitioners said that they do find probiotics to be helpful to address side effect symptoms.   
2a: Which side-effect symptoms are you concerned about? 
All nine practitioners listed diarrhea or loose stools first as a symptom of concern.  Gastro 
intestinal symptoms including heartburn, GI upset, and gastritis were identified by 44% (n = 4) 
of respondents.  Yeast overgrowth was voiced as a concern in 44% (n = 4) of the responses 
noting specifically skin and oral thrush.  Only 22% (n = 2) of NPs mentioned VVC, and one NP 
identified balanitis as a potential concern (interestingly, two NPs specifically noted diabetes as a 
risk factor related to yeast overgrowth secondary to antibiotic use).  Three (33%) nurse 
practitioners pointed out the preventative use of probiotics so that symptoms do not develop. 
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Question 3: If you recommend probiotics to patients, how do you recommend they be 
taken? 
The most common response (44%) to recommending how to take probiotics was to 
follow the directions on the package (n = 4).  One nurse practitioner stated that if package 
directions state one a day, but they are taking antibiotics, taking 2 or 3 each day of probiotic 
treatment would be recommended.  Although 44% (n = 4) NPs spoke of the following package 
directions, more than half or 55% (n = 5) referred to yogurt when discussing probiotics.  Of 
these, two NPs stated “live active cultures”, one NP stated  “Activa” – a name brand.  Three 
interviewees voiced concern for sugar in yogurt and diabetes was stressed as a reason for 
concern.  Only one interviewee recommended patients take the probiotic prior to antibiotic use. 
Interestingly, only one NP specifically stated that probiotics would not be recommended 
to patients.  This practitioner did not cite ineffectiveness as the reason, but that probiotics are an 
added expense and patients in the free clinic setting cannot afford them.  This NP also cited 
lower health literacy for patients and stated “most patients just want the antibiotic and be done 
with it”. 
Question 4: Do patients ask about probiotic use when you prescribe antibiotics? 
Describe or explain how you respond. 
All nine nurse practitioners stated that patients seldom ask about probiotics.  Most NPs, 
66% (n = 6) replied that when probiotics are discussed it is most often the nurse practitioner that 
first suggests their use.  One nurse noted that when patients return for subsequent visits, they 
sometimes mention picking up a probiotic “once the seed had been previously planted”.   
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Question 5: What kind of education or recommendations do you regularly provide to 
patients regarding side effects such as GI upset, diarrhea, yeast infection or 
other symptoms that they may experience with antibiotic use? 
Explain or describe your usual practices reading patient teaching. 
All nine nurse practitioners had some patient education advice or materials regarding 
taking antibiotics that they shared with or provided to patients.  Many educational materials 
focused on antibiotic effectiveness such as completing the antibiotic course, taking the antibiotic 
at the prescribed time or at the same time every day, and “connecting the antibiotic to another 
activity such as breakfast and dinner” so that it isn't forgotten.  Less than half, 44% (n = 4) stated 
that they regularly address possible side effects of antibiotic use to their patients.  Interviewee 
responses included taking medications with food to reduce stomach upset; three practitioners 
specifically stated what types of food to take with antibiotics, such as foods with a higher fat 
content.  Three practitioners recommended increasing yogurt intake during the antibiotic 
treatment for cases that they considered at higher risk for side effects. 
Questions 6: How do you feel about co-prescribing antifungal treatments such as Diflucan 
when you prescribe antibiotics? 
All interviewees acknowledged that many patients with a history of yeast infection ask 
for Diflucan prescriptions.  All except one practitioner, 88% (n = 8) stated that if a patient 
requests a prescription for Diflucan that they would provide it.  Six of these interviewees (66%) 
were very clear that the patient has to request Diflucan, they never are first to bring up the topic.  
Two practitioners stated that if they see that Diflucan has been prescribed to that patient on a 
previous visit that they might ask the patient if they would like that again.  Other interview 
comments included that denying a request for Diflucan was a barrier to care, and that patients 
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expect to receive it when they request it.  One practitioner stated that not giving the prescription 
makes patients feel unheard or not respected and will encourage the patient to go to another 
provider or place for their care in the future.  One practitioner expressed concern for comorbid 
conditions and medication interactions although this practitioner would not deny the request. 
NPs offered patient education on the use of Diflucan.  Patient education focused on 
waiting until the antibiotic is complete, 77% (n = 7), waiting until symptoms develop 77% (n = 
7), and not taking the medication prophylactically 11% (n = 1).  One NP recommended 
generating a “wait and see” prescription for Diflucan so the prescription is not available until 
after the antibiotic is finished.  Finally, one respondent completely disagreed with the practice of 
prescribing Diflucan; this NP referred women to an over-the-counter yeast treatment product or 
recommended returning for professional diagnosis if symptoms persisted.   
Discussion 
All of the respondents had direct experience in the project subject matter of antibiotic-
associated side effects.  The average number of years in practice was 9.6 years, which indicates 
ample practice experience in prescribing medications and educating patients.  Most nurse 
practitioners interviewed recognized a clinical value for probiotics for certain symptoms, patient 
populations, or scenarios.   
A role for probiotics in the management of GI symptoms such as diarrhea was widely 
recognized by the healthcare providers.  Although this indication strongly correlates with the 
evidence supporting probiotics for gastrointestinal symptoms including diarrhea and gastritis 
(Avadhani & Steefel, 2015; McFarland, 2015; World Gastroenterology, 2011) their knowledge 
of evidence-based recommendations for probiotic use did not correlate to the evidence.  Several 
practitioners discussed the importance of maintaining balance of natural flora throughout the 
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body.  This indication is also is supported by literature (McFarland, 2015; World 
Gastroenterology, 2011).  The NPs note certain scenarios when probiotics would be useful such 
as after colonoscopy, following viral illness, and with antibiotic use.  Antibiotic use as an 
indication is well documented in the literature (Avadhani & Steefel, 2015; McFarland, 2015; 
Rodgers, et al., 2013; World Gastroenterology, 2011) the indications of post-colonoscopy and 
following viral illness are not specified in the literature, but GI literature was not a primary focus 
of this literature search.  The nurse practitioners interviewed seemed to be considering causes of 
diarrhea and that is consistent with the literature.  The NPs spoke of health literacy, populations 
likely to be receptive to probiotic use, and the inability of some patients to afford the 
supplements.  The evidence selected did not address health literacy in respect to probiotic use, 
although the identification of middle-aged women years old did match with literature (Avadhani 
& Steefel, 2015), as well as the affordability of probiotic supplements (Avadhani & Steefel, 
2015; McFarland, 2015).  No practitioners discussed VVC in response to this question. 
Nurse practitioners are well-experienced at prescribing antibiotics.  Further, most of the 
NPs noted specific antibiotics or mentioned broad-spectrum antibiotics as likely to cause side 
effects for patients.  Articles studied did list broad-spectrum antibiotics as a risk factor for 
antibiotic-associated side effects (Hanson, et al., 2016; Pirotta, et al., 2004).  The NPs did 
pinpoint certain scenarios where probiotics would be helpful such as conditions needing higher 
doses of antibiotics (ear infections, animal bites), and cases where a second round of antibiotics 
was necessary.  The literature did not specify causes that might be of higher risk for side-effect 
symptoms.  The results from the interviews reveal that the nurse practitioners were aware of the 
findings from the literature based on their own experiences with patients.   
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Diarrhea or loose stools was a common symptom of concern voiced by the nurse 
practitioners interviewed.  This side effect of antibiotic use is supported by the evidence of 
probiotic usefulness in cases of diarrhea (Avadhani & Steefel, 2015; McFarland, 2015; Rodgers, 
et al., 2013; World Gastroenterology, 2011).  Yeast overgrowth was also voiced as a concern by 
the providers, specifically skin and oral thrush.  These indications were supported by weaker 
evidence and this was not the primary focus in the search inclusion.  Diabetes was mentioned by 
two NPs as a risk factor however, the literature did not identify this additional risk, nor was it a 
search inclusion for this project.  The findings from the interviews suggest that side effects of 
antibiotic use are a concern of nurse practitioners however when suggesting probiotic use to 
combat these side effects their suggestions to patients may not be based on the best or current 
evidence.   
Nurse practitioners interviewed rely on manufacturers packaging for guidance and 
information; advice not examined in any of the reviewed studies.  One nurse practitioner stated 
that if package directions state one a day, but they are taking antibiotics, taking 2 or 3 each day 
of probiotic treatment would be recommended, this was consistent with research (Avadhani & 
Steefel, 2015; McFarland et.al, 2015).  Only one interviewee recommended patients take the 
probiotic prior to antibiotic use.  This advice was inconsistent with the evidence that is specific 
about separation doses by 2-4 hours (Avadhani & Steefel, 2015; Neafsey, 2005). 
More than half of NPs recommended yogurt as a probiotic.  Of these, two NPs stated 
“live active cultures”, one NP stated “Activa” – a name brand.  The research was specific that 
not every yogurt is a probiotic (World Gastroenterology, 2011; McFarland et.al, 2015) and that 
live or active cultures are essential for yogurt to be an effective probiotic (World 
Gastroenterology, 2011; McFarland et.al, 2015) The brand name “Activa” was not noted in the 
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evidence although the brands “DanActive” was singled out as effective in one study (Hu, et al, 
2013).   
Surprisingly, all nine nurse practitioners stated that patients seldom ask about probiotics.  
Most NPs, replied that when probiotics are discussed it is most often the nurse practitioner that 
first suggests their use.  There is no research data included that correlates to this research 
question.  All nine nurse practitioners interviewees had some patient education advice or 
materials regarding taking antibiotics that they shared with or provided to patients.  For most, the 
education had to do with completing the course, or taking with food; suggestions that were not 
researched or consistent with the objectives of this project.  Specific foods were identified, a 
factor addressed only in one older study (Neafsey, 2005).  Yogurt was recommended by three 
NPs, two mentioning live cultures in this question, a third just mentioning yogurt.  The evidence 
suggests that to be considered a probiotic, a yogurt must contain, live, active cultures (World 
Gastroenterology, 2011; McFarland et.al, 2015).   
All interviewees acknowledged that many patients with a history of yeast infection ask 
for Diflucan prescriptions.  All except one practitioner would provide it.  It should be noted that 
no articles were identified addressing this topic; Diflucan use was not the focus of this project. 
Overall, nurse practitioners did not proactively address the known complication of VVC 
in susceptible patients unless the patient initiated the concern by requesting Diflucan.  Interview 
questions regarding VVC were intentionally excluded to avoid leading responses.  Interestingly, 
no nurse practitioners discussed the black box warning of Diflucan that was added in the past 
year recognizing a link between Diflucan and miscarriage (Davis Drug Guide, 2016).  This was a 
concern to the author as the population most susceptible to VVC is women of childbearing age.   
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Conclusions 
Although this quality improvement project initially focused on VVC, it became evident 
that while scientific evidence is stronger for use of probiotics with gastrointestinal symptoms; the 
evidence for use of probiotics for VVC symptoms is weak.  While nurse practitioners are using 
probiotics clinically for symptoms consistent with research (i.e., GI symptoms), gaps in 
knowledge do exist that may prevent effective probiotic use.  For example, if using probiotics for 
GI symptoms, if patients are not taught to space the antibiotic or probiotic products, then they 
may feel that the probiotics are ineffective without realizing that taking the products together has 
rendered the probiotic ineffective.  Broad dissemination of current recommendations via an 
Executive Summary and in peer-reviewed journals for clinical practitioners may help to improve 
practice. 
The source of probiotic information was an interesting finding in this project.  All nurse 
practitioners stated that their formal education included no information on the use of probiotics.  
Common sources of information reported included product advertising, professional periodicals, 
and colleagues.  Including some information on these products in pharmacology courses may 
help improve the ability of practitioners to best serve their patients.   
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Chapter Five: Implications to Practice 
Practice Change Recommendations 
While no significant practice changes were uncovered in this project, gaps in knowledge 
were identified that once remediated can improve patient medication compliance and enhance 
the clinician relationship in teaching patients how best to protect themselves and their families 
from discomforts related to antibiotic therapy.  Publishing the recommendations in a professional 
journal for practitioners may help to improve practice by educating prescribers on the evidence-
based recommendations that can improve treatment for their patients. 
The evidence reveals that use of probiotics in the prevention or treatment of VVC is weak 
and does not support their use in clinical practice at this time.  Evidence for probiotics for 
treatment of GI symptoms, both in the presence of antibiotics and in general is strong (Avadhani 
& Steefel, 2015; McFarland et.al, 2015; World Gastroenterology, 2011).  Probiotic use in clinical 
practice must be based on human studies that support the intended health benefit.  The research 
has uncovered these recommendations for optimal probiotic treatment: 
(a) Yogurts used as probiotics should contain live or active cultures, not every yogurt is 
considered a probiotic (World Gastroenterology, 2011; McFarland et.al, 2015). 
(b) 8-16 Ounces of yogurt with live cultures added provide similar health benefits as oral 
supplements (McFarland et.al, 2015). 
(c) Probiotic sources should contain 1-10 billion units of bacteria (McFarland et.al, 2015; 
World Gastroenterology, 2011). 
(d) Probiotics should be avoided in patients with high fevers or immunodeficiency 
(Avadhani & Steefel, 2015). 
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(e) Avoid administering probiotics and antibiotics simultaneously as the antibiotic is 
likely to destroy the probiotic in the GI tract (Avadhani & Steefel, 2015; Neafsey, 
2005; McFarland et.al, 2015). 
(f) When taking probiotics to prevent GI symptoms caused by antibiotics, the doses 
should be separated by two to four hours (Avadhani & Steefel, 2015; Neafsey, 2005). 
(g) When taking probiotics to prevent or treat antibiotic-associated GI symptoms, 
probiotics should be taken three to four times daily (Avadhani & Steefel, 2015). 
(h) When taking probiotics to replace flora disrupted by antibiotic therapy, the 
supplement should be continued for two weeks after the antibiotic treatment is 
finished (McFarland et.al, 2015). 
(i) Probiotic supplements should be taken in capsule form with an enteric coating to 
promote absorption in the small intestine and prevent destruction of the cultures by 
stomach acid (Avadhani & Steefel, 2015; Neafsey, 2005). 
(j) Read the package directions of any supplement before taking. 
Limitations 
The response rate for the interview snowball recruitment was nine out of nineteen, or 
47%.  According to Stommel and Wills (2004), response rates lower than 80% are associated 
with some level of bias.  The NPs invited received a recruitment letter that introduced the focus 
of the project.  It is possible that NPs that did not feel comfortable discussing their knowledge or 
professional practices declined the invitation while practitioners who were more knowledgeable 
or confident chose to participate.  This selective option may have contributed to bias.   
A PNP was included in the participants. PNPs do not treat the age group selected for the 
project and thus may have contributed to bias for GI symptoms. The age range selected for this 
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project was 21 to 45 years of age. The age of 18 is the age of consent and if repeated, women 
between the ages of 18 and 45 should be included. 
 The open-ended question format, and the goal of limiting the interview to six questions 
may have inadvertently limited the findings.  Although interesting findings were uncovered, 
more detailed questioning may have produced more detailed responses.  Repeating the project 
with questions regarding VVC, effective organisms, and a broader recruitment method would 
likely produce more specific and useful results. 
Implications for Nursing Practice and the Doctor of Nursing Practice Essentials 
The DNP Essentials of Doctoral Education for Advanced Practice Nurses (American 
Association of Colleges of Nursing, 2006) and their relevance to this project include: 
Essential I: Scientific underpinnings for practice.   
Scientific underpinnings include nursing theories, models, and philosophies.  In this 
project, the theoretical framework of PARIHS, designed as a guide to implement EBP in clinical 
practice was used.  The Iowa model was applied to navigate the intricacies of change.  Finally, 
the literature evaluation and synthesis of the evidence-based literature are the foundation 
providing the scientific underpinnings of advanced practice nursing. 
Essential II: Organizational and systems leadership for quality improvement and 
systems thinking.   
Systems leadership encompasses the facilitation of multiple interacting and intersecting 
systems to affect change.  This essential was represented through navigation of the corporate 
environment, the college environment, and the project plan.  All parties were not in agreement on 
the goals and definition of the project requiring organizational and systems leadership to 
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navigate a path to successful project completion including an executive summary of evidence-
based practice recommendations.   
Essential III: Clinical scholarship and analytical methods for evidence-based 
practice. 
This essential is represented in the DNP project in identifying the problem, performing a 
methodical literature review, analysis of evidence-based literature, and translation of findings 
into clinical practice recommendations.  Analytic methods to interpret the data allowed the 
identification of studies and articles of highest statistical worth.   
Essential IV: Information systems/technology and patient care technology for the 
improvement and transformation of healthcare.   
This essential was represented through the comprehensive literature search.  Melnyk’s 
Center for Transdisciplinary Evidence Based Practice Rapid Critical Appraisal Tool (2011) was 
utilized to analyze and identify data of highest statistical worth.  These skills are instrumental in 
obtaining appropriate and accurate health information evidence on which to base change. 
Essential V: Healthcare policy for advocacy in health care.  Remediation of patient 
teaching points and dissemination of findings should lead to policy change at the clinic level so 
that practice is current with evidence. 
Essential VI: Inter-professional collaboration for improving patient population. 
Assuming leadership roles and employing effective communication skills were essential to the 
project’s successful completion. 
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Essential VII: Clinical prevention and population health for improving the nation’s 
health.   
This essential is at the core of this DNP project.  Probiotics as a prevention to improve 
the patient experience and improve medication compliance with antibiotics does contribute to the 
nation’s health.  This project employing health promotion and risk reduction improves the 
patient’s treatment experience.   
Essential VIII: Advanced nursing practice.   
This project sought to identify what NPs taught their patient and compared this to current 
evidence identifying what exactly we should be teaching patients about probiotics when an 
antibiotic is prescribed.  Nurse practitioners are well known for patient-centered education and 
holistic a view of the patient.  The results of this project clarify evidence-based recommendations 
for probiotic use, improving patient experiences and advancing nursing practice.   
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Appendix A 
EBP Synthesis Table 
 
Author / 
Study 
 
LOE / 
Design 
 
Year 
 
Pertinent Sample 
Characteristics 
 
Specific 
Probiotic 
 
Intervention 
 
Major 
findings r/t 
PICOT 
Abad & Safdar 
The role of 
Lactobacillus 
Probiotics in the 
Treatment of 
Prevention of 
Urogenital 
Infections – A 
Systematic 
Review 
 
 
 
 
 
 
 
I 
Systematic 
Review 
2009 Examined 25 studies to 
evaluate effectiveness 
of probiotic on 
development of BV, 
UTI, and VVC 
Lactobacillus Women with recurrent 
infections, not 
necessarily related to 
ABX use. Probiotic 
compared to no 
treatment 
Significant 
benefit for BV. 
Evidence for 
prevention in 
UTI or VVC was 
“uncertain” 
Bohbot, J. M., & 
Cardot, J. M. 
 
Vaginal impact 
of the Oral 
Administration 
of Total Freeze-
Dried Culture of 
LCR 35 in 
Healthy Women 
 
II  
Randomized 
RCT 
2011 20  women childbearing 
age in Paris 
 
10 Women in each 
group ages 18-45 years 
old, premenopausal, 
non-pregnant with 
effective contraception, 
non-immunodeficient, 
no anti-infectious tx.  
Lactobacillus 
casei rhamnosus 
(LCR 55) 
effectiveness of 2 doses 
LCR35 
vaginal uptake of 
different doses 
may demonstrate 
greater use of 
probiotics as 
prophylactic tx  
 
Both groups 
positive effect,  
higher dose had 
better outcome  
 
Positive 
relationship 
between oral and 
vaginal uptake 
 
Further research 
is necessary to 
specify 
preventative or 
curative impact 
Hanson, et al. 
Probiotics for 
Treatment and 
prevention of 
Urogenital 
Infections in 
Women: A 
systematic 
Review 
I 
Systematic 
Review 
2008-
2015 
20 Studies Reviewed  Of 20 studies, 2 focused 
on VVC 
“Variable 
findings” 
 
Results did not 
indicate 
usefulness in 
prevention or 
treatment, but 
ongoing use of 
probiotic can 
help prevent 
recurrence 
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Hu, et al. 
 
Impact of Eating 
Probiotic Yogurt 
on Colonization 
by Candida 
Species of the 
Oral and Vaginal 
mucosa in HIV-
infected and 
HIV-uninfected 
women 
 
 
III 
Pilot study as 
part of an 
ongoing 
longitudinal 
study 
2013 24 Women (17 HIV+, 7 
HIV-), Georgetown 
University. Exclusion: 
women 
w/hysterectomies, 
trying to conceive, or tx 
w/any antifungal during 
study period. 
 
some women were 
HIV+ thus likely 
immune-compromised 
2 Branded 
products 
represented the 
two major 
genera 
 
Less fungal 
colonization in 
all  groups 
consuming 
probiotic yogurt 
54% none 
probiotic period,  
29% 
w/DanActive, 
38% w/YoPlus 
The Women went 60 
days without yogurt, 
then DanActive (one 3.1 
oz container per day) for 
15 days, followed by a 
30-day wash out period, 
and finally a 15 days 
course of YoPlus (one 
4oz container per day) 
yogurt. Oral and vaginal 
samples were obtained 
at each completion 
point, 4 in all 
addresses 
probiotic in 
yogurt form  
 
Addressed 
treatment and 
prevention  
 
Less fungal 
colonization in 
all  groups 
consuming 
probiotic yogurt 
54% none 
probiotic period,  
29% 
w/DanActive,  
38% w/YoPlus  
 
significant 
difference 
between the two 
yogurt types 
 
“No statistically 
significant 
differences were 
found between 
treatment 
periods, and non-
treatment 
periods” 
McFarland, L 
From Yaks to 
Yogurt: The 
History, 
Development, 
and Current Use 
of Probiotics 
VII 
Article/Expert 
Opinion 
2015  Acidophilus, 
Lactobacillus 
Patient beliefs, 
marketing, evidence-
based efficiency 
indications 
VVC not well 
studied (6% of 
research) 
 
Evidence of other 
uses for 
probiotics 
Neafsey, P 
Bugs, Drugs, and 
Yogurt 
VII 
Expert opinion 
2005 Review of studies in 
early 2005, admits that 
studies do not meet 
EBP criteria but do 
show positive 
correlation 
w/Lactobacillus 
Lactobacilli Specific 
recommendations 
regarding dosing, and 
how to administer as 
preventative measure 
Specifically 
supportive of 
PICOT 
Pendharkar, et al. 
 
Vaginal 
colonization by 
probiotic 
lactobacilli can 
clinical outcome 
in women 
conventionally 
treated for 
bacterial 
vaginosis and 
yeast infection 
III  
2 consecutive 
open-label pilots 
2011 40 Scandinavian 
women w/ BV, VVC, 
or clinical symptoms.  
> 18 years old, non 
pregnant, no signs of 
other GU infection.   
 
Dual probiotic 
containing 
Lactobacillus 
rhamnosis & 
Lactobacillus 
gasseri 
Labeled as 
EcoVag 
#1: BV only tx w/ 
clindamycin & 
metronidazole followed 
by EcoVag 5 days after 
each atb tx. 
2: BV and Yeast: 
divided to 3 groups: 
a) BV receiving 
clindamycin and 
metronidazole w/ 
EcoVag for 10 days 
after each atb tx then 
weekly tx for 4 months. 
b) R-VVC 
receiving extended 
fluconazole and 
EvoVag tx 
c) extended 
fluconazole tx only 
d)  
Product contains 
2 strains 
Lactobacillus  
Treatment 
effective for 
BV, further 
studies needed 
for VVC 
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Pirotta, et al. 
 
The PAV trial: 
Does 
lactobacillis 
prevent post-
antibiotic 
vulvovaginal 
candidiasis? A 
randomized 
controlled trial 
II 
Randomized, 
placebo 
controlled, 
double blind, 
factorial 2x2 
trial 
2004 235 Women 18-50 
years old, starting a 
short term  
atb for non-uro/gyn 
acute infection 
 
50 general practices & 
16 pharmacies in 
Melbourne Australia 
 
Lactobacillus Compare oral VS 
vaginal administration 
of probiotic 
largest quality 
study to 
investigate the 
effects of 
probiotic use in 
prevention of 
VVC 
 
Treatment was 
deemed 
ineffective 
 
Study stopped 
early due to result 
 
results in 
opposition to 
common practice 
Pirotta & 
Garland 
Her Choice: 
Dealing with 
Lactobacilli, 
Vaginitis, and 
Antibiotics 
VII 
Expert Opinon 
by 
researcher of 
PAV trial 
2005  Lactobacillus Discusses historic 
acceptance in medical 
community and ages old 
patient belief. 
 
Believes that most VVC 
is not accurately 
diagnosed (is self 
diagnosed by patients) 
“Despite being 
a popular folk 
remedy with 
decades of 
acceptance and 
use evidence is 
weak.” 
Reid & Bruce 
Urogenital 
infections in 
women: can 
probiotics help 
VII 
Article/Expert 
opinion 
2003 Discussion of 
pathophysiology, 
organisms, many 
references to existing 
studies, but not a 
systematic review 
Several N/A – discussion No scientific 
evidence of 
antifungal 
activity. 
Vicariotto, et al.  
Effectiveness of 
the association of 
2 probiotic 
strains 
formulated in a 
slow release 
vaginal product, 
in women 
affected by 
vulvovaginal 
candidiasis; a 
pilot study 
III  
Pilot Study 
2012 30 Women diagnosed 
with VVC, prone to 
recurrence. 
Dual probiotic 
agent containing 
Lactobacillus 
fermentum LF10 
& Lactobacillus 
acidophillus 
All received 
intervention 
 
Results compared to 
previous study 
recurrence points. 
 
Intravaginal product 
Nearly all had 
success in 1st 
month. All but 
three avoided 
recurrence in 2nd 
month. 
Dual probiotic 
with success 
“effectiveness in 
acute VVC 
infection, but 
does not offer 
long term 
protection in 
recurrence” 
Legend: LOE=Level of evidence, VVC=Vulvovaginal candidiasis, BV=Bacterial Vaginosis, Tx=treatment 
 
 
  
EVIDENCE BASED PRIOBIOTIC RECOMMENDATIONS 
 
45 
Appendix B 
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Appendix C 
DISCLOSURE AND CONSENT FORM 
 
Project Title: Beliefs and Practices of Nurse Practitioners Related to the Use and Recommendation of 
Probiotics in the Prevention or Treatment of Antibiotic-Associated Side Effects.  
 
You are being invited to participate in a quality-improvement project being conducted by 
Donnamarie Burris, a Doctor of Nursing Practice student enrolled at the Ohio State University. Please 
review this form prior to your participation so that you are aware of potential risks and how the 
information you provide will be used. If you decide to take part in the project, your responses will be 
anonymous.  
The purpose of the project is to evaluate the beliefs and practices of nurse practitioners regarding 
the use or recommendation of probiotic products. Survey results will be compared to current evidence to 
describe and analyze best practices of uses for probiotics in the clinical setting. The results from these 
interviews may help other nurse practitioners in augmenting their practice recommendations in the 
clinical uses and effectiveness of probiotics as adjunctive treatment.  
The interview will be conducted in-person in a private and confidential location at the 
convenience of the participant. The interview will last approximately ten to fifteen minutes. The 
interviewer will make handwritten notes on the interview form, and the interview will be recorded 
without including information about the participant or other identifying information. The recording will 
be destroyed after it has been transcribed and confirmed to be accurate.  
The interview will consist of six questions, plus follow up questions if appropriate. Optional 
demographic information will be collected. Although the questions have been structured to avoid risks, 
you do not have to answer any questions that you do not want to answer. If you decide to quit at any time 
prior to completing the survey, your answers will not be recorded. There may be no direct benefit to you 
by participating in the project.  
Information about you will be kept confidential to the extent permitted or required by law. After 
data collection is completed, all participant contact information will be destroyed. If there are any 
professional presentations or publications about this study or survey responses, your name, practice name, 
e-mail address, or postal address will not be included. 
By beginning the interview, you acknowledge that you have read this information and agree to 
participate in this research survey, with the knowledge that you are free to withdraw your participation at 
any time without penalty.  
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Appendix D 
Interview Questions 
1. What are your thoughts and experiences regarding the clinical recommendation of 
probiotics for patients? 
 
 
2. Do you prescribe antibiotics? If so, what is your experience with the efficacy of 
probiotics to prevent or treat antibiotic-associated side effects? 
 
2a.  What symptoms are you concerned about? 
 
2b I do not recommend probiotics to my patients who are taking antibiotics. 
 
3. If you recommend probiotics to patients, how do you recommend they be taken? 
 
 
3a If you do not recommend them, can you tell me why you do not? 
 
4. Do patients ask about probiotic use when you prescribe antibiotics? 
Describe or explain how you respond. 
 
 
5. What kind of education or recommendations do you regularly provide to patients 
regarding side effects such as GI upset, diarrhea, yeast infection or other symptoms that 
they may experience with antibiotic use? 
 
Explain or describe your usual practices reading patient teaching. 
 
 
6. How do you feel about co-prescribing antifungal treatments such as Diflucan when you 
prescribe antibiotics? 
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Appendix E 
 
INVITATION TO PARTICIPATE  
IN A DOCTORATE OF NURSING PRACTICE (DNP) PROJECT  
REGARDING PROBIOTICS 
 
 
You are being invited to participate in a quality-improvement project being conducted by 
Donnamarie Burris, a Doctor of Nursing Practice student enrolled at the Ohio State University. The 
purpose of the project is to evaluate the beliefs and practices of nurse practitioners regarding the use or 
recommendation of probiotic products. The results from this project may help other nurse practitioners in 
augmenting their practice recommendations in the clinical uses and effectiveness of probiotics as 
adjunctive treatment.  
Your participation in the project will be voluntary and anonymous. The interview will be 
conducted in-person in a private and confidential location at your convenience. The interview will last 
approximately ten minutes. The interview will consist of six questions, plus follow up questions if 
appropriate. Optional demographic information will be collected. Although the questions have been 
structured to avoid risks, you do not have to answer any questions that you do not want to answer. If you 
decide to quit at any time prior to completing the survey, your answers will not be recorded.  
Thank you for your consideration and contribution to the future of our profession. I know your 
time is valuable and I am grateful for the opportunity to include your input in my findings. If you are 
willing to participate, please contact me, the student, by either phone or email listed below. 
 
Sincerely, 
 
 
Donnamarie Burris 
(602) 363-3108 
DonnamarieBurris@gmail.com 
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Appendix F 
 
Beliefs and Practices of Nurse Practitioners Related to the Use and Recommendations of 
Probiotics for the Prevention of Antibiotic-Associated Vulvovaginal Candidiasis in Adult-aged 
Women: An Opportunity for Evidence-based Practice Change. 
 
EXECUTIVE SUMMARY 
Donnamarie Burris, MSN, RN, CNP 
 
Subject Matter / Purpose 
The purpose of this quality improvement project was twofold:  
(a) Conduct semi-structured interviews to explore the beliefs and current practices of Nurse 
Practitioners (NPs) that prescribe antibiotic therapy in the outpatient setting, regarding 
probiotic products 
(b) Compare these beliefs and practices to the best current evidence. A synthesis of the 
literature was conducted to describe and critically analyze current best practices of 
probiotic use in the clinical setting.  
Methods of Analysis 
The project design included qualitative semi-structured interviews of nine NPs identified 
using a snowball recruitment method. Responses were recorded on an interview form and 
common themes to each question were analyzed. Responses were compared to current evidence-
based literature from sixteen peer-reviewed articles that examined the effectiveness of probiotics 
in the prevention or treatment of certain antibiotic associated side effects. 
Findings 
Although the practitioners’ beliefs of symptoms to address with probiotics were generally 
consistent with current best evidence, gaps in knowledge were identified. The recommendation 
of probiotic strains and the number of cultures contained in the supplement were discussed in 
some interviews but was not always in agreement with the literature. Similarly, suggestions 
regarding the frequency and timing of dosing between the probiotic and the antibiotic voiced by 
the practitioners were often inconsistent with the research findings.  
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Conclusions 
Although this quality improvement project initially focused on VVC, it became evident 
that while scientific evidence is stronger for use of probiotics with gastrointestinal symptoms; the 
evidence for use of probiotics for VVC symptoms is weak. While nurse practitioners are using 
probiotics clinically for symptoms consistent with research (i.e., GI symptoms), gaps in 
knowledge do exist that may prevent effective probiotic use. For example, if using probiotics for 
GI symptoms and patients are not taught to space the antibiotic or probiotic products, then they 
may feel that the probiotics are ineffective without realizing that taking the products together has 
rendered the probiotic ineffective. Broad dissemination of current recommendations via an 
Executive Summary and in peer-reviewed journals for clinical practitioners may help to improve 
practice. 
The source of probiotic information was an interesting finding in this project. All nurse 
practitioners stated that their formal education included no information on the use of probiotics. 
Common sources of information reported included product advertising, professional periodicals, 
and colleagues. Including some information on these products in pharmacology courses may 
help improve the ability of practitioners to best serve their patients. The results from the semi-
structured interviews may augment practice recommendations in clinic settings and effectiveness 
of probiotics as adjunctive treatment. 
 
Recommendations 
The main recommendation for the use of probiotics is to suggest probiotics when 
antibiotics are prescribed to prevent or treat antibiotic-associated diarrhea. Current evidence 
suggests that probiotics are not effective to prevent or treat vulvovaginal candidiasis.The 
research has uncovered these recommendations for optimal probiotic treatment: 
(k) Yogurts used as probiotics should contain live or active cultures.  
(l) 8-16 Ounces of yogurt with live cultures added provide similar health benefits as oral 
supplements.  
(m) Probiotic sources should contain 1-10 billion units of bacteria.  
(n) Probiotics should be avoided in patients with high fevers or immunodeficiency. 
(o) Avoid administering probiotics and antibiotics simultaneously as the antibiotic is 
likely to destroy the probiotic in the GI tract.  
(p) When taking probiotics to prevent GI symptoms caused by antibiotics, the doses 
should be separated by two to four hours.  
(q) When taking probiotics to prevent or treat antibiotic-associated GI symptoms, 
probiotics should be taken three to four times daily.  
(r) When taking probiotics to replace flora disrupted by antibiotic therapy, the 
supplement should be continued for two weeks after the antibiotic treatment is 
finished. 
(s) Probiotic supplements should be taken in capsule form with an enteric coating to 
promote absorption in the small intestine and prevent destruction of the cultures by 
stomach acid. 
(j)  Read the package directions of any supplement before taking. 
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Limitations of the Report 
The response rate for the interview snowball recruitment was 47%, response rates lower 
than 80% may be associated with some level of bias. The NPs invited received a recruitment 
letter that introduced the focus of the project. It is possible that NPs that did not feel comfortable 
discussing their knowledge or professional practices declined the invitation while practitioners 
who were more knowledgeable or confident chose to participate. This selective option may have 
contributed to bias.  
 The open-ended question format, and the goal of limiting the interview to six questions 
may have inadvertently limited the findings. Although interesting findings were uncovered, more 
detailed questioning may have produced more detailed responses. Repeating the project with 
questions regarding VVC, effective organisms, and a broader recruitment method would likely 
produce more specific and useful results. 
